HappeningToo topic
Gemcitabine Hydrochloride reports
Browse community reports connected to Gemcitabine Hydrochloride. These reports can show that other people are describing similar experiences, but they do not prove that Gemcitabine Hydrochloride caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
24 problems
Abdominal Pain while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and abdominal pain appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and alopecia appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and back pain appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and chills appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and constipation appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and cough appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and decreased appetite appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and dehydration appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and diarrhea appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and dizziness appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and fatigue appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and headache appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and hypotension appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and itching appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and malaise appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and nausea appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and pain appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and peripheral swelling appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and rash appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and shortness of breath appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and skin redness appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and vomiting appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and weakness appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Gemcitabine Hydrochloride
FDA FAERS contains adverse-event reports in which Gemcitabine Hydrochloride and weight decreased appear together. This does not establish that Gemcitabine Hydrochloride caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →